TC Biopharm (Holdings) Plc (TCBPY)
OTCMKTS
· Delayed Price · Currency is USD
0.2800
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT
TC Biopharm (Holdings) Employees
TC Biopharm (Holdings) had 41 employees as of December 31, 2023. The number of employees decreased by 19 or -31.67% compared to the previous year.
Employees
41
Change (1Y)
-19
Growth (1Y)
-31.67%
Revenue / Employee
n/a
Profits / Employee
-$356,739
Market Cap
114.91K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 41 | -19 | -31.67% |
| Dec 31, 2022 | 60 | -16 | -21.05% |
| Dec 31, 2021 | 76 | -4 | -5.00% |
| Dec 31, 2020 | 80 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Glass House Brands | 374 |
| Elite Pharmaceuticals | 64 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 9 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
| Longduoduo Company | 49 |
TC Biopharm (Holdings) News
- 18 days ago - TCBP Announces Grant of European Patent for Targeting of Microbial, Oncological, and Viral Indications using Modified Gamma Delta T Cells - PRNewsWire
- 5 weeks ago - TCBP Announces Transition from Nasdaq to OTC Markets - PRNewsWire
- 5 weeks ago - TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead - PRNewsWire
- 7 weeks ago - TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company - PRNewsWire
- 2 months ago - TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum - PRNewsWire
- 2 months ago - TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial - PRNewsWire
- 2 months ago - TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial - PRNewsWire
- 2 months ago - TCBP to Implement ADS Ratio Change - PRNewsWire